These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39216733)

  • 1. Insight of the molecular mechanism of inhibitors located at different allosteric sites regulating the activity of wild type and mutant KRAS (G12).
    Liu Y; Li Y; Li G; Wang A; Chu H
    Arch Biochem Biophys; 2024 Oct; 760():110137. PubMed ID: 39216733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.
    Zhang Y; Larraufie MH; Musavi L; Akkiraju H; Brown LM; Stockwell BR
    Biochemistry; 2018 Feb; 57(8):1380-1389. PubMed ID: 29313669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
    Xu K; Park D; Magis AT; Zhang J; Zhou W; Sica GL; Ramalingam SS; Curran WJ; Deng X
    Mol Cancer; 2019 Apr; 18(1):85. PubMed ID: 30971271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling.
    Pantsar T; Rissanen S; Dauch D; Laitinen T; Vattulainen I; Poso A
    PLoS Comput Biol; 2018 Sep; 14(9):e1006458. PubMed ID: 30199525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-Ras
    Feng H; Zhang Y; Bos PH; Chambers JM; Dupont MM; Stockwell BR
    Biochemistry; 2019 May; 58(21):2542-2554. PubMed ID: 31042025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel peptide inhibitors for oncogenic KRAS G12D as therapeutic options using mutagenesis-based remodeling and MD simulations.
    Samad A; Khurshid B; Mahmood A; Rehman AU; Khalid A; Abdalla AN; Algarni AS; Wadood A
    J Biomol Struct Dyn; 2023; 41(22):13425-13437. PubMed ID: 37010994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsecond Molecular Dynamics Simulation to Gain Insight Into the Binding of MRTX1133 and Trametinib With KRAS
    Ancy I; Penislusshiyan S; Ameen F; Chitra L
    J Mol Recognit; 2024 Nov; 37(6):e3103. PubMed ID: 39318275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation.
    Lu J; Bera AK; Gondi S; Westover KD
    Biochemistry; 2018 Jan; 57(3):324-333. PubMed ID: 29235861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
    Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
    J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into small-molecule KRAS inhibitors for targeting KRAS mutant cancers.
    Pandey D; Chauhan SC; Kashyap VK; Roy KK
    Eur J Med Chem; 2024 Nov; 277():116771. PubMed ID: 39167893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanism of Phosphorylation-Mediated Impacts on the Conformation Dynamics of GTP-Bound KRAS Probed by GaMD Trajectory-Based Deep Learning.
    Chen J; Wang J; Yang W; Zhao L; Zhao J; Hu G
    Molecules; 2024 May; 29(10):. PubMed ID: 38792177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico comparative analysis of KRAS mutations at codons 12 and 13: Structural modifications of P-Loop, switch I&II regions preventing GTP hydrolysis.
    Gerber M; Goel S; Maitra R
    Comput Biol Med; 2022 Feb; 141():105110. PubMed ID: 34920161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
    Ostrem JM; Peters U; Sos ML; Wells JA; Shokat KM
    Nature; 2013 Nov; 503(7477):548-51. PubMed ID: 24256730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The higher level of complexity of K-Ras4B activation at the membrane.
    Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
    FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement.
    Lee KY; Fang Z; Enomoto M; Gasmi-Seabrook G; Zheng L; Koide S; Ikura M; Marshall CB
    Angew Chem Int Ed Engl; 2020 Jun; 59(27):11037-11045. PubMed ID: 32227412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States.
    Gentile DR; Rathinaswamy MK; Jenkins ML; Moss SM; Siempelkamp BD; Renslo AR; Burke JE; Shokat KM
    Cell Chem Biol; 2017 Dec; 24(12):1455-1466.e14. PubMed ID: 29033317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of Mutations in the P-Loop on Conformational Alterations of KRAS Investigated with Gaussian Accelerated Molecular Dynamics Simulations.
    Shi S; Zheng L; Ren Y; Wang Z
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.
    Chen CC; Er TK; Liu YY; Hwang JK; Barrio MJ; Rodrigo M; Garcia-Toro E; Herreros-Villanueva M
    PLoS One; 2013; 8(2):e55793. PubMed ID: 23437064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-target, ensemble-based virtual screening yields novel allosteric KRAS inhibitors at high success rate.
    Gupta AK; Wang X; Pagba CV; Prakash P; Sarkar-Banerjee S; Putkey J; Gorfe AA
    Chem Biol Drug Des; 2019 Aug; 94(2):1441-1456. PubMed ID: 30903639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An NMR comparison of the changes produced by different guanosine 5'-triphosphate analogs in wild-type and oncogenic mutant p21ras.
    Miller AF; Halkides CJ; Redfield AG
    Biochemistry; 1993 Jul; 32(29):7367-76. PubMed ID: 8338834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.